GFM
ANIP icon

GF Fund Management’s ANI Pharmaceuticals ANIP Stock Holding History

GF Fund Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5K Sell
477
-27
-5% -$2.17K ﹤0.01% 417
2026
Q1 		$38.8K Buy
504
+63
+14% +$4.92K ﹤0.01% 428
2025
Q4 		$34.8K Sell
441
-26
-6% -$2.25K ﹤0.01% 447
2025
Q3 		$42.8K Sell
467
-71
-13% -$5.79K ﹤0.01% 413
2025
Q2 		$35.1K Hold
538
– – ﹤0.01% 448
2025
Q1 		$36K Buy
538
+97
+22% +$5.79K ﹤0.01% 447
2024
Q4 		$24.4K Buy
+441
New +$25.3K ﹤0.01% 455

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's ANIP Position: Q2 2026 in Review

GF Fund Management reduced its ANI Pharmaceuticals (ANIP) stake by 5.4% in Q2 2026, selling an estimated $2.17K and leaving 477 shares worth $39.5K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

GF Fund Management first reported a position in ANIP in Q4 2024 and has held it in 7 quarters since. The position peaked at $42.8K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • GF Fund Management held 477 shares of ANI Pharmaceuticals worth $39.5K as of Q2 2026.
  • GF Fund Management sold 27 ANI Pharmaceuticals shares in Q2 2026, an estimated $2.17K.
  • ANI Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #417 holding.
  • GF Fund Management first reported a position in ANI Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's ANI Pharmaceuticals position peaked at $42.8K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.